| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | NS3988A2TC |
| InChI Key | YIDDLAAKOYYGJG-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H24FN7O |
| Molecular Weight | 445.5 |
| AlogP | 4.68 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 90.52 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 33.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Mitogen-activated protein kinase kinase kinase 5 inhibitor | PubMed |
| Primary Target | |
|---|---|
| mitogen-activated protein kinase kinase kinase 5 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
STE protein kinase group
STE protein kinase STE11 family
STE protein kinase ASK
|
- | 6247 | - | - | - | |
|
Enzyme
Kinase
Protein Kinase
STE protein kinase group
STE protein kinase STE11 family
|
2 | 3-24 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetic Nephropathies | 2 | D003928 | ClinicalTrials |
| Hypertension, Pulmonary | 2 | D006976 | ClinicalTrials |
| Hepatitis, Alcoholic | 2 | D006519 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1448428-04-3 |
| ChEMBL | CHEMBL3916717 |
| DrugBank | DB14916 |
| FDA SRS | NS3988A2TC |
| Guide to Pharmacology | 9040 |
| PDB | NJV |
| PubChem | 71245288 |
| SureChEMBL | SCHEMBL14672984 |
| ZINC | ZINC000149387856 |